|
|
|
|
|
Alin M. Jose, Avuthu Tejaswi, Eswaran Kokiladevi, Niharika Sharma and Kalenahalli Yogendra
Aflatoxins, carcinogenic secondary metabolites produced by the Aspergillus fungi, pose a significant threat to groundnut, making them susceptible to infection and compromising their quality. Despite extensive breeding programs, the need for more durable ...
ver más
|
|
|
|
|
|
|
|
|
|
|
Alnakhli Naseer, Salman Mo, Steven C. Olsen and Brian McCluskey
Background: Brucella melitensis is recognized as one of the predominant zoonotic pathogens globally. Live-attenuated vaccine Rev 1 is currently the most effective vaccine for controlling B. melitensis in small ruminants. While Brucella inactivated, nanop...
ver más
|
|
|
|
|
|
|
|
|
|
|
Kyoung-Ok Jang, Chaeyeon Yu, Hangeun Kim and Dae-Kyun Chung
Human ß-defensin 3 (hBD3) is an antimicrobial peptide and a chemoattractant molecule expressed in human keratinocytes. Lysates prepared from Lactoplantibacillus plantarum KG (KG lysates), a fermented lactobacillus strain with Ginseng extracts, significan...
ver más
|
|
|
|
|
|
|
|
|
|
|
Hsiang-Chieh Chuang, Yin-Ze Shi, Chiu-Min Cheng, Chieh-Yu Pan and Ann-Chang Cheng
In Taiwan, the mushroom Antrodia camphorata (AC) is used for medicinal purposes, including cancer prevention and treatment. This study aimed to investigate the effect of AC-supplemented diets on the innate immunity and disease resistance of the orange-sp...
ver más
|
|
|
|
|
|
|
|
|
|
|
Claude Roth, Félix G. Delgado, Etienne Simon-Lorière and Anavaj Sakuntabhai
Despite numerous efforts to identify the molecular and cellular effectors of the adaptive immunity that induce a long-lasting immunity against dengue or Zika virus infection, the specific mechanisms underlying such protective immunity remain largely unkn...
ver más
|
|
|
|
|
|
|
|
|
|
|
Heather Eggleston and Peter Panizzi
Molecular imaging by definition is the visualization of molecular and cellular processes within a given system. The modalities and reagents described here represent a diverse array spanning both pre-clinical and clinical applications. Innovations in prob...
ver más
|
|
|
|
|
|
|
|
|
|
|
U. Gadde, H. D. Chapman, T. Rathinam, and G. F. Erf
Pág. 2243 - 2250
|
|
|
|
|
|